Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea

Diagnostic Microbiology and Infectious Disease

Volumn 76, Issue 4, 2013, Pages 486-490

  Kim, So Yeon ^a   Shin, Juyoun ^a   Shin, Sang Yop ^b   Ko, Kwan Soo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korea Medical Institute   (South Korea)

Author keywords

Klebsiella pneumoniae; NDM 1; Polymyxins; ST11; Tigecycline

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; BETA LACTAMASE CTX M; BETA LACTAMASE IMP 1; BETA LACTAMASE NDM 1; BETA LACTAMASE VIM 2; CARBAPENEM; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; POLYMYXIN B; RIFAMPICIN; TETRACYCLINE; TIGECYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; BLACTX M GENE; BLAGIM GENE; BLAIMP GENE; BLAKPC GENE; BLANDM GENE; BLAOXA 48 GENE; BLASIM GENE; BLASPM GENE; BLATEM GENE; BLAVIM GENE; CITROBACTER FREUNDII; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENE IDENTIFICATION; GENE SEQUENCE; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; KOREA; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

KLEBSIELLA PNEUMONIAE; NDM-1; POLYMYXINS; ST11; TIGECYCLINE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; MULTILOCUS SEQUENCE TYPING; MUTATION; POLYMYXINS; PORINS; REPUBLIC OF KOREA;

EID: 84880759706     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.04.006     Document Type: Article

References (26)

1. Cardoso O., Alves A.F., Leitão R. Metallo-β-lactamase VIM-2 in Pseudomonas aeruginosa isolates from a cystic fibrosis patient. Int J Antimicrob Agent 2008, 31:375-379.
2. Performance standards for antimicrobial susceptibility testing, 21st informational supplement (M100-S21). 2011, Clinical and Laboratory Standards Institute. (CLSI), CLSI, Wayne, PA.
3. Damjanova I., Tóth A., Pászti J., Hajbel-Vékony G., Jakab M., Berta J., et al. Expansion and countrywide dissemination of ST11, ST15, and ST147 ciprofloxacin-resistant CTXM-15-type b-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005 - the new 'MRSAs'?. J Antimicrob Chemother 2008, 62:978-985.
4. Diancourt L., Passet V., Verhoef J., Grimont P.A., Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005, 43:4178-4182.
5. Doumith M., et al. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 2009, 63:659-667.
6. Garcia-Fernandez A., et al. An ertapenem-resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant. Antimicrob Agents Chemother 2010, 54:4178-4184.
7. Gupta N., Limbago B.M., Patel J.B., Kallen A.J. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011, 53:60-67.
8. Hidron A.I., Edwards J.R., Patel J., et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008, 29:996-1011.
9. Kim M.N., Yong D., An D., Chung H.S., Woo J.H., Lee K., et al. Nosocomial clustering of NDM-1-producing Klebsiella pneumoniae sequence type 340 strains in four patients at a South Korean tertiary care hospital. J Clin Microbiol 2012, 50:1433-1436.
10. Ko K.S., Lee J.Y., Baek J.Y., Suh J.Y., Lee M.Y., Choi J.Y., et al. Predominance of an ST11 ESBL-producing Klebsiella pneumoniae clone causing bacteraemia and urinary tract infections in Korea. J Med Microbiol 2010, 59:822-828.
11. Landman D., Bratu S., Quale J. Contribution of Omp36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. J Med Microbiol 2009, 58:1303-1308.
12. Lau S.H., Reddy S., Cheesbrough J., Bolton F.J., Willshaw G., Cheasty T., et al. Major uropathogenic Escherichia coli strain isolated in the northwest of England by multilocus sequence typing. J Clin Microbiol 2008, 46:1076-1080.
13. Leclercq R., Cantón R., Brown D.F.J., Giske C.G., Heisig P., MacGowan A.P., et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 2013, 19:141-160.
14. Lee M.Y., Choi H.J., Choi J.Y., Song M., Song Y., Kim S.W., et al. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea. J Infect 2010, 60:146-153.
15. Lee M.Y., Ko K.S., Kang C.I., Chung D.R., Peck K.R., Song J.H. High prevalence of CTX-M-15-producing Klebsiella pneumoniae isolates in Asian countries: diverse clones and clonal dissemination. Int J Antimicrob Agents 2011, 38:160-163.
16. Nation R.L., Li J. Colistin in the 21st century. Curr Opin Infect Dis 2009, 22:535-543.
17. Nordmann P., Naas T., Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011, 17:1791-1798.
18. Nordmann P., Dortet L., Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm!. Trends Mol Med 2012, 18:263-272.
19. Peirano G., Pillai D.R., Pitondo-Silva A., Richardson D., Pitout J.D. The characteristics of NDM-producing Klebsiella pneumoniae from Canada. Diagn Microbiol Infect Dis 2011, 71:106-109.
20. Peleg A.Y., Adams J., Paterson D.L. Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii. Antimicrob Agents Chemother 2007, 51:2065-2069.
21. Pitout J.D., Laupland K.B. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166.
22. Poirel L., Al Maskari Z., Al Rashdi F., Bernabeu S., Nordmann P. NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. J Antimicrob Chemother 2011, 66:304-306.
23. Rhee J.Y., Park Y.K., Shin J.Y., Choi J.Y., Lee M.Y., Peck K.R., et al. KPC-producing extreme-drug resistant (XDR) Klebsiella pneumoniae isolate from a patient with diabetic mellitus and chronic renal failure on hemodialysis in South Korea. Antimicrob Agents Chemother 2010, 54:2278-2279.
24. Suh J.Y., Son J.S., Chung D.R., Peck K.R., Ko K.S., Song J.H. Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea. Antimicrob Agents Chemother 2010, 54:560-562.
25. Tzouvelekis L.S., Markogiannakis A., Psichogiou M., Tassios P.T., Daikos G.L. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012, 25:682-707.
26. Woodford N., Turton J.F., Livermore D.M. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 2011, 35:736-755.